The Civics and Cents of Life Sciences IP 2025: Assessing the Political and Economic Impact of the Federal Approach to Life Sciences Patents Under a New Administration

Sterne Kessler Director Deborah Sterling, Ph.D., was a panelist during the ACI Life Sciences Patents conference, May 19-20, 2025, in New York, NY. The panel “The Civics and Cents of Life Sciences IP 2025: Assessing the Political and Economic Impact of the Federal Approach to Life Sciences Patents under a New Administration” discussed the major shifts we can expect to the life sciences patent landscape, including:

• How the priorities of new leadership at the FDA, USPTO, and FTC will influence life sciences IP
• The status of March-In Rights
• The impact of the Loper decision on administrative action
• Current and pending legislation, including the Inflation Reduction Act, PREVAIL, RESTORE, and PERA
• The current slate of cases before the Supreme Court and what these pending decisions will mean for life sciences patents